Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India | PLOS ONE
Frontiers | Current and Future Direct-Acting Antivirals Against COVID-19
Direct-Acting Antiviral Agents for Treatment of Hepatitis C Virus... | Download Scientific Diagram
Cureus | Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection | Article
Pathogens | Free Full-Text | Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence
Viruses | Free Full-Text | Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma - ScienceDirect
Hepatitis C Virus Treatment von Kazuaki Chayama | ISBN 978-981-10-2415-3 | Fachbuch online kaufen - Lehmanns.de
Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure? - Asselah - 2018 - Liver International - Wiley Online Library
Viruses | Free Full-Text | Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice
Hepatitis C Treatment in the Era of Direct-Acting Antiviral Agents: Challenges in Developing Countries - ScienceDirect
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights | Nature Reviews Gastroenterology & Hepatology
Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus | SpringerLink
Classification of the new direct-acting antivirals because of their... | Download Table
Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China
Directly acting antiviral agents vs Host directed antiviral agents | DAAs vs HDAs| - YouTube
In Brief: Hepatitis B Reactivation with Direct-Acting Antiviral Drugs for Hepatitis C | The Medical Letter Inc.
Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy | Bentham Science
Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus | SpringerLink
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection – Dr. Leonardo Riella
Potent SARS-CoV-2 Direct-Acting Antivirals Provide an Important Complement to COVID-19 Vaccines | ACS Central Science
Management of acute HCV infection in the era of direct-acting antiviral therapy | Nature Reviews Gastroenterology & Hepatology
Study of Adverse Drug Effects of Direct-Acting Antivirals for Chronic HCV Infection at Fayoum Governorate, Egypt - A Pharmacovigilance Study | Bentham Science
The four classes of direct-acting antiviral agents | Download Table
Hepatoma Research
Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting - ScienceDirect
Viruses | Free Full-Text | Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
